NEW YORK Jan. 17 2017 PRNewswire Immune Pharmaceuticals NASDAQ IMNP "Immune" a clinical stage biopharmaceutical company announced today that it will hold a Satellite Symposium on February 20th 2017 at the International Symposium on Acute Leukemi...
↧